92 DAFTAR PUSTAKA
American Society of Health-System Phamacist, 1997, ASHP Guideline on Phamacist-Conducted Patient Education and Conducted Patient Education and Conseling, Am. J. Health-Syst. Pharm, 54: 162-73.
American Society Health-System Pharmacist, 2006, ASHP Therapeutic Position Statement in the Treatment of Hypertension, Am. J. Health-Syst. Pharm.,63: 1074-80.
Anonim, Faktor Resiko Terjadinya Hipertensi, Juli 11, 2007b, diakses 22 Oktober 2009 (http://www.smallcrab.com/kesehatan/25-healthy/87-faktor-risiko-terjadinya-hipertensi
Asti, Tri, 2006, Kepatuhan Pasien : Faktor Penting dalam Keberhasilan Terapi. Info POM, Vol. 7, No. 5, diakses Januari 2011 dari http:// perpustakaan.pom.go.id/KoleksiLainnya/Buletin%20Info%20POM/0506. pdf
Azwar, S., 2003, Reliabilitas dan Validitas, Pustaka Pelajar, Yogyakarta.
Barry, L.C. 2004, Implementing the New Guidelinees for Hypertension : JNC VII, ADA, WHA-ISH, J Management Care Pharm.,10 (5):18-25.
Bart, S., 1994, Psikologi Kesehatan, PT. Gramedia Widiasarana Indonesia, Jakarta, hal 32-6.
Basuki, Endang, 2009, Konseling Medik : Kunci Menuju Kepatuhan Pasien. Majalah Kedokteran Indonesia, Vol 59 Nomor 2 Februari 2009.
Basuki, B. and Setianto, B. 2001, Age, Body Posture, Daily Working Load-Past Antihypertensive Drugs and Risk of Hypertension: a Rural Indonesia Study, Med J Indon, 10: 29-33.
Chasani S, 2009, Management of High Risk Hypertension, Universitas Diponegoro, 165-170.
Chasani S, 2011, Candesartan Delays Disease Progression in Patient with High Normal Blood Pressure (Prehypertension), Universitas Diponegoro, 41-47.
Chobanian, A.V., Bakris, G.L., Black, H.R., Cuhsman, W.C., Green, L. 2003, National High Blood Pressure Education Program Co-ordinating Committee, The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. JAMA, 289: 3560-3572.
93 Cipolle, R.J., Strand, L.M., Morley, P.C. 2004, Pharmaceutical Care Practice: The
Clinican’s Guide, 2nd edition, The McGraw Hill Co. New York.
Dahlan, Sopihudin, 2001, Statistik untuk Kedokteran dan Kesehatan, edisi 5, Salemba Medika, Jakarta. Indonesia.
Darmojo, B, 2000, ‘Mengamati Penelitian Epidemiologi Hipertensi di Indonesia’, dipresentasikan pada Seminar Hipertensi PERKI di Jakarta, 9 November 2000.
Departemen Kesehatan RI, 2006, Pharmaceutical Care untuk Penyakit Hipertensi. Direktorat Jenderal Bina Farmasi, Jakarta, hal 18.
Departemen Kesehatan RI, 2007, Pharmaceutical Care untuk Penyakit Hipertensi, Pendoman Konseling Pelayanan Kefarmasian di Sarana Kesehatan. Direktorat Jenderal Bina Farmasi, Jakarta, hal 12.
Dipiro, J.T., Talbert, R.L., Yee, G.C., Matzke, G.R., Wells, B.G., Posey, L.M. 2005, Pharmacotherapy A Pathophysiologic Approach, Sixth Edition, McGraw-Hill, New York: 185-214.
Ernst, R. 2000, Blood Pressure Lowering Treatment Trialist’ Collaboration. Effect ACE Inhibitors, Calcium Antagonist, and Other Blood Pressure Lowering Drugs. Lancet, 356 : 1955-1964.
Hajjar I, Kotchen TA. Trends In Prevalence, Awareness, Treatment, And Control Of Hypertension In The United States, 1998 – 2000. JAMA 2003;290:199-206.
Hashmi, S.K, Afridi, M.B., Abbas, K., Sajwani, R.A., Saleheen D., et al. 2007, Factors Associated with Adherence to Anti-Hypertensive Treatment in Pakistan, New England J Medicine,33: 280-296.
Haynes, R.B., Taylor, D.W., Sackett, D.L., Gibson, E.S., Bernholz, C.D., Mukhreje J., 1980, Can Simple Clinical Measurements Detect Patient Noncomliance., Hypertension, 2:757-64.
Haynes, R.B., Mc. Donald, H.P., Garg, A.X. 2002, Helping Patients Follow Prescribed Treatment : Clinical Applications, JAMA, 288:2880-83. Hughes, J., Keen, N., Dillon, M. 2001, Hypertension : Improving Patient
Compliance and Clinical Outcome Through Community Pharmacist Manage Care, Final Report, Pharmacy Practice Research Grant, pp : 169-173.
94 Hussar, DA, 1995, Patient Compliance, in Remington: The Science and Practice of Pharmacy, Volume II, USA, The Philadelphia College of Pharmacy and Science, Philadelphia, pp 1796-1807.
Hyman DJ, Characteristic Of Patients With Uncontrolled Hypertension In The United States. NEJM 2001;345:479-486.
Jepson, M.H, 1990, Patient Compliance and Counselling, Diana M., Aulton, ME.(Editor), London: Pharmaceutical Practice, Churscill Livingstone.
Jin, J., Sklar, G.E., 2008, Factors affecting therapeutic compliance: A review from the patient’s perspective, National Center for Biotechnology Information, pp: 4: 269-286.
Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. 2003, The Seventh Report of the JNC (JNC 7), JAMA, 289: 2560-72.
Kaplan, NM, 2002, Clinical Hypertension, 8nd edition, Williams & Wilkins, Lippincott. USA.
Kementerian Kesehatan RI, 2008, Pharmaceutical Care untuk Penyakit Hipertensi, Jakarta; Kementerian Kesehatan Republik Indonesia
Kementerian Kesehatan RI, 2010, Pedoman Konseling Pelayanan Kefarmasian di Sarana Kesehatan. Jakarta; Kementerian Kesehatan Republik Indonesia Kusumaningjati, 2007, ‘Pengaruh Konseling Farmasis Terhadap Luaran Terapetik
Pasien Hipertensi di RSU Kardinal Tegal’, Tesis, MSc, Fakultas Farmasi, Universitas Gadjah Mada, Yogyakarta.
Laurence, L.B., Lazo, J.R., Parker, K.L. 2008, Manual Phamacology and Therapeutics.7ndedition, Mc Graw Hill, New York.
Lee, J.K., Grace K.A., Taylor A.J. 2006, Effect of Pharmacy Care Program on Medication Adherence and Persistense, Blood Pressure, and Low Density Lypoprotein Cholesterol: A Randomized Controlled Trial, JAM Medical Assosiation,296:2563-2571
Lindberg, M., Estrim T., 2001, Asthma Care and Factors Affecting Medication Compliance: The Patient’s Point of View, International J Quality Health Care, 13(5):375-383
Morisky, D.E., Ang A Krousel-Wood, M.A., Ward H 2008, Predictive Validity if A Medication Adherence Measure in an Outpatient Setting, J. Health-Syst. Pharm., 10:348-54.
95 Mulyasih, A.B. 2010, ‘Pengaruh Konseling Apoteker Terhadap hasil Terapi Pasien Hipertensi di Poliklinik Penyakit dalam RSUD Kraton Kabupaten Pekalongan’, Tesis, MSc, Fakultas Universitas Gadjah Mada, Yogyakarta.
Notoatmodjo, S., 2003, Pendidikan dan Perilaku Kesehatan, Rineka Cipta, Jakarta, Indonesia, hal 42-5.
Nafrialdi, 2007, Antihipertensi dalam Farmakologi dan Terapi, Edisi 5, EGC, Jakarta. Indonesia.
Palaian, S., Mukhyaprana, P., Ravi, S. 2006, Patient Counseling by Pharmacist Focus on Chronic Illness, Pak J. Pharm Sci, 19 (1) : 62-65.
Rantucci, MJ., 2007. Komunikasi Apoteker-Pasien (Edisi 2). Penerjemah : A. N. Sani. Jakarta : Penerbit Kedokteran EGC.
Redline,S. Kualitas tidur yang buruk meningkatkan tekanan darah pada remaja, Oktober 06, 2008, diakses 25 Juli 2009
(http://www.kalbe.co.id/print_version.php?mn=news&detail=19764)
Schnipper, JL, Jennifer, LK, Michael, CC, Stephanie, AW, Brandon, AB, Emily, T, Allen, K, Mark, H, Christoper, LR, Sylvia, CM, David, WB. 2006. Role of Pharmacist Counseling in Preventing Adverse Drug Events After Hospitalization. USA : Archives Internal Medicine. Vol 166.565-571.
Sja’bani M, 2009, How We Choose Combination of Antihypertensive Drugs?, Universitas Diponegoro, 261-262.
Sja’bani M, 2011, High Dose Fixed Combination Therapy of ARB and Diuretics in Severe Hypertension, Universitas Diponegoro, 91-101.
Saragi, S. 2011, Panduan Penggunaan Obat, Rosemata Publisher, Jakarta, hal 1-36. Saseen, J.J., Carter, B.L., 2005, Essential Hypertension, in : Koda Kimble, M.A.,
Young, L.Y., Kradjan, W.A., Guglielmo, B.J., Alldredge, B.K., dan Corelli, R.L., eds) : Applied Therapeutics : The Clinical Use of Drugs, Eight Edition, New York : Lippincot Williams & Wilkin, Chapter : 14.1-43.
Saseen, J.J., Carter, B.L., 2008, Hypertension, in : Dipiro, J.T., Talbert, R.L., Yee, G.C., Matzke, G.R., Wells, B.G., Posey, L.M. 2008, Pharmacotherapy A Pathophysiologic Approach, Seventh Edition, New York, McGraw-Hill, P: 139-171.
96 Setiawan, Zamhir. 2004, ‘Karakteristik Sosiodemografi Sebagai Faktor Resiko Hipertensi Studi Ekologi Di Pulau Jawa’, Tesis, MSc., Universitas Indonesia, Jakarta.
Setiawati, A. dan Bustami, Z. 2005. Farmakologi dan Terapi, Edisi 4, UI Press, Jakarta. Indonesia.
Sodoyo, A.W, Setiyohadi, B., Alwi, I., 2006, Buku Ajar Ilmu Penyakit Dalam, Jilid II, Edisi IV, Jakarta: Pusat Penerbitan Departemen Ilmu Penyakit Dalam, Fakultas Kedokteran Universitas Indonesia, 1079-85.
Surahman, E., Husein, I, 2011 Konsep Dasar Pelayanan Kefarmasian Berbasiskan Pharmaceutical Care. Widya Padjadjaran, Bandung, hal 5
Susalit, E., Kapojos, E.J., Lubis, H. R., 2001, Hipertensi Primer, dalam Buku Ajar Ilmu Penyakit Dalam, Jilid 2, Edisi III, 453-454, 460-465 Balai Penerbit Fakultas Kedokteran Universitas Indonesia, Jakarta
Vasan RS, 2001, Impact of High Normal Blood Pressure on the Risk of Cardiovascular Disease, Ifalic ;345:1291-1297
World Health Organization, 2003 a, Adherence to Long-Term Therapies-Evidence for Action, 108th, Switzerland, WHO.
World Health Organization, 2003 b, International Society of Hypertension Writing Group, World Health Organization-Internasional Society of hypertension statement of Management of Hypertension, 108-17.
World Health Organization, 2005, Clinical Guidelines for the Management of Hypertension, 29th,Cairo University, Egypt, WHO.
Yogiantoro, M., 2006, Hipertensi Esensial, dalam : Sudoyo, A.W., Setiyohadi, B., Alwi, I., dkk, (eds) : Buku Ajar Ilmu Penyakit Dalam, Jilid II, Edisi IV, Jakarta : Pusat Penerbitan Departemen Ilmu Penyakit Dalam, Fakultas Kedokteran Universitas Indonesia, pp.: 1079-85.
